NEW YORK (GenomeWeb) – Twist Bioscience announced today that it has signed a non-exclusive agreement with Synbio Technologies, a biotech company that focuses on DNA technology and applications.

The companies will work in tandem to provide customers worldwide with access to genes up to 70 kilobases in length.

"By leveraging our collective expertise in next-generation gene synthesis, we believe we will see new uses of DNA to improve the diagnosis and treatment of diseases," Synbio CEO Ping Yang said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.